Why a popular breast cancer drug may be less effective for some Africans

People who inherit two copies of variant show five times less active drug in bloodstreams.

On average, a fifth of Africans carry at leas two ne copy of variant that the five archers studied studied.

Each year, around 200,000 people in sub-Saharan Africa receive diagnoses of breast cancer. November 2 ss=" the American Society of Human Genetics 00 annual n> 20 100,000 about 28 fifth ghtT Africans Gi">40 at least one n> the United States 5 percent ">Tw over 34 percent Kanji African Americans Comfort Kanji >Kanji the African Institute of Biomedical Science and Technology Harare as Zimbabwe ryFeed_highLightText__NxlGi">estrogen about 30 percent Kanji tText__NxlGi">Worldwide daily an class="summaryFee 42 h Zimbabweans t__NxlGi">Kanji one ghLightText__NxlGi">Africa two lass third maryFeed_highLightText__NxlGi">the United States 86 percent longer than five years Fewer than 40 percent two pan class="summaryFeed_highLightText__NxlGi">Africa around 200,000 Each year David Twesigomwe xt__NxlGi">cliniciansthe Sydney Brenner Institute for Molecular Bioscience rica Johannesburg